These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 15979006)
1. Coxibs and NSAIDs--clearing the air. Moskowitz RW; Abramson SB; Berenbaum F Osteoarthritis Cartilage; 2005 Jul; 13(7):545-7. PubMed ID: 15979006 [No Abstract] [Full Text] [Related]
2. [Selective inhibitors of cyclooxigenase-2 (Coxibs) and cardiovascular morbidity]. Ruilope LM; Coca A Med Clin (Barc); 2002 Feb; 118(6):219-21. PubMed ID: 11864545 [No Abstract] [Full Text] [Related]
3. Global safety of coxibs and NSAIDs. Pham K; Hirschberg R Curr Top Med Chem; 2005; 5(5):465-73. PubMed ID: 15974941 [TBL] [Abstract][Full Text] [Related]
4. Taking stock of coxibs. Drug Ther Bull; 2005 Jan; 43(1):1-6. PubMed ID: 15679077 [TBL] [Abstract][Full Text] [Related]
6. Increased risk of cardiovascular events with coxibs and NSAIDs. Dachman R Lancet; 2005 Apr 30-May 6; 365(9470):1537-8. PubMed ID: 15866298 [No Abstract] [Full Text] [Related]
7. The coxibs, selective inhibitors of cyclooxygenase-2. Rich SA N Engl J Med; 2001 Dec; 345(23):1709. PubMed ID: 11759657 [No Abstract] [Full Text] [Related]
8. Life after Vioxx: the clinical implications. Fortun PJ; Hawkey CJ Hosp Med; 2005 May; 66(5):264-7. PubMed ID: 15920854 [No Abstract] [Full Text] [Related]
9. Coxibs and cardiovascular disease. Fitzgerald GA N Engl J Med; 2004 Oct; 351(17):1709-11. PubMed ID: 15470192 [No Abstract] [Full Text] [Related]
10. Increased risk of cardiovascular events with coxibs and NSAIDs. Scott DG; Watts RA Lancet; 2005 Apr 30-May 6; 365(9470):1537. PubMed ID: 15866299 [No Abstract] [Full Text] [Related]
11. [A step back or training pain?]. Raeder J Tidsskr Nor Laegeforen; 2005 Aug; 125(15):2050-1. PubMed ID: 16100553 [No Abstract] [Full Text] [Related]
12. Comment on Jüni P, Dieppe P. Older people should NOT be prescribed 'coxibs' in place of conventional NSAIDs. Stichtenoth DO; Frölich JC Age Ageing; 2004 Sep; 33(5):521. PubMed ID: 15315931 [No Abstract] [Full Text] [Related]
13. The lessons of Vioxx. Frazier KC N Engl J Med; 2005 Sep; 353(13):1420-1; author reply 1420-1. PubMed ID: 16192497 [No Abstract] [Full Text] [Related]
14. Matters of the heart: assessing the cardiovascular safety of new drugs. Konstam MA Am Heart J; 2003 Oct; 146(4):561-2. PubMed ID: 14564304 [No Abstract] [Full Text] [Related]
15. [Cardiovascular and gastrointestinal safety of NSAIDs]. van den Bemt P; Tjwa ET; van Oijen MG Ned Tijdschr Geneeskd; 2014; 158():A7311. PubMed ID: 24713339 [TBL] [Abstract][Full Text] [Related]
16. [Withdrawal of rofecoxib: a sign to be careful with coxibs in patients with increased cardiovascular risk]. Bijlsma JW Ned Tijdschr Geneeskd; 2004 Oct; 148(44):2162-4. PubMed ID: 15559407 [TBL] [Abstract][Full Text] [Related]
17. Review of coxib adverse effects notified in France. Prescrire Int; 2003 Feb; 12(63):21. PubMed ID: 12602396 [No Abstract] [Full Text] [Related]
18. Summing the risk of NSAID therapy. Scheiman JM; Fendrick AM Lancet; 2007 May; 369(9573):1580-1. PubMed ID: 17499583 [No Abstract] [Full Text] [Related]
19. Trying times for painkiller choices. Vioxx, Bextra, and Celebrex can increase the risk for heart attack and other cardiovascular problems. So can the old standbys, like ibuprofen and acetaminophen. Harv Heart Lett; 2006 Oct; 17(2):1-3. PubMed ID: 17153752 [No Abstract] [Full Text] [Related]